AKT1 and cancer: Our results also suggest that TGF-β dependent proliferation of the cancer cells requires TMEPAI-PTEN-PI3K/Akt signaling axis, as PI3K inhibitors (Fig.5E) or wild type PTEN (Fig. 9A) could completely inhibit cell growth.